Pharma Utility: Your Source for Pharmaceutical News & Insights

Volume 19 . Issue 1

Pharmaceutical Industry and the Road to SDG 2030: A Public Health Perspective

Sustainable pharma growth isn’t just about scale—it’s about being inclusive, resilient, and regenerative. With its global influence, India’s pharma industry can lead the way in advancing health equity and environmental responsibility.

Latest News

News

Zydus receives final approval from USFDA for Glatiramer Acetate Injection, the generic version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes

By Pharmautility

News

Indian Pharma Majors Breathe Easy as US Spares Sector from Reciprocal Tariffs

By Pharmautility

News

Zydus Chairman Mr. Pankaj Patel Honoured with Padma Bhushan for Transformative Contributions to Lifesciences

By Pharmautility

Latest Press Releases

Press Release

OneSource’s flagship drug-device combination facility in Bangalore maintains its USFDA compliance status

By Pharmautility

Press Release

Guttify launches India’s First Clinically-Guided At-Home Fatty Liver Management Kit – “Liver Lift”

By Pharmautility

Press Release

Glenmark Pharmaceuticals to Launch DCGI-approved BRUKINSA® in India to Advance Treatment of Hematological Malignancies

By Pharmautility

Press Release

Servier India introduces ‘Ivosidenib’ (Tibsovo®), in India, First-in-class Targeted Therapy in Oncology for Rare IDH1-Mutated AML and Cholangiocarcinoma

By Pharmautility

Press Release

Zydus gets exclusive licensing rights for next genimmuno-oncology platforms from the US based Agenus

By Pharmautility

Upcoming Events

Event

Asia LabEx

June 11 - June 13

Event

5th Edition: India Biopharma Leaders Conclave

June 4 - June 5

Event

BBB Summit & Expo

May 8 - May 9

Event

3rd Annual Pharma Impurity Conclave 2025

May 8 - May 9

Event

Pharma SFE/ SFA Summit & Awards

May 9

Event

Analytica Lab India 2025

April 23 - April 25

Latest Issues

ISSUE

Pharma Utility – Pharmaceutical Industry and the Road to SDG 2030 – A Public Health Perspective

ISSUE

Pharma Utility – Continuing the 18 Years of Legacy in the Pharma Industry

ISSUE

H.E.L Group Appoints Professor Yih-Shing Duh as Chief Scientific

ISSUE

Global quality experts call for strengthening quality culture & leveraging technological advancements at IPA’s 9th Global Pharmaceutical Quality Summit 2024

Latest Press Releases

Press Release

Refining high-purity battery metals with Lewatit MK51 from LANXESS

LANXESS is offering a new solution for the rapidly growing battery industry. The Lewatit MK 51 ion exchange resin from LANXESS selectively removes boron from metal concentrates, thus enabling the extraction of high-purity raw materials for use in batteries.

By Pharmautility

Press Release

OneSource’s flagship drug-device combination facility in Bangalore maintains its USFDA compliance status

By Pharmautility

Press Release

Guttify launches India’s First Clinically-Guided At-Home Fatty Liver Management Kit – “Liver Lift”

By Pharmautility

Press Release

Glenmark Pharmaceuticals to Launch DCGI-approved BRUKINSA® in India to Advance Treatment of Hematological Malignancies

By Pharmautility

Press Release

Servier India introduces ‘Ivosidenib’ (Tibsovo®), in India, First-in-class Targeted Therapy in Oncology for Rare IDH1-Mutated AML and Cholangiocarcinoma

By Pharmautility

Pharmaceutical Industry and the Road to SDG 2030: A Public Health Perspective

Latest News

Zydus receives final approval from USFDA for Glatiramer Acetate Injection, the generic version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes

Indian Pharma Majors Breathe Easy as US Spares Sector from Reciprocal Tariffs

Zydus Chairman Mr. Pankaj Patel Honoured with Padma Bhushan for Transformative Contributions to Lifesciences

Latest Press Releases

OneSource’s flagship drug-device combination facility in Bangalore maintains its USFDA compliance status

Guttify launches India’s First Clinically-Guided At-Home Fatty Liver Management Kit – “Liver Lift”

Glenmark Pharmaceuticals to Launch DCGI-approved BRUKINSA® in India to Advance Treatment of Hematological Malignancies

Servier India introduces ‘Ivosidenib’ (Tibsovo®), in India, First-in-class Targeted Therapy in Oncology for Rare IDH1-Mutated AML and Cholangiocarcinoma

Zydus gets exclusive licensing rights for next genimmuno-oncology platforms from the US based Agenus

Upcoming Events

Asia LabEx

5th Edition: India Biopharma Leaders Conclave

BBB Summit & Expo

3rd Annual Pharma Impurity Conclave 2025

Pharma SFE/ SFA Summit & Awards

Analytica Lab India 2025

Latest Issues

Pharma Utility – Pharmaceutical Industry and the Road to SDG 2030 – A Public Health Perspective

Pharma Utility – Continuing the 18 Years of Legacy in the Pharma Industry

H.E.L Group Appoints Professor Yih-Shing Duh as Chief Scientific

Global quality experts call for strengthening quality culture & leveraging technological advancements at IPA’s 9th Global Pharmaceutical Quality Summit 2024

Latest Press Releases

Refining high-purity battery metals with Lewatit MK51 from LANXESS

OneSource’s flagship drug-device combination facility in Bangalore maintains its USFDA compliance status

Guttify launches India’s First Clinically-Guided At-Home Fatty Liver Management Kit – “Liver Lift”

Glenmark Pharmaceuticals to Launch DCGI-approved BRUKINSA® in India to Advance Treatment of Hematological Malignancies

Servier India introduces ‘Ivosidenib’ (Tibsovo®), in India, First-in-class Targeted Therapy in Oncology for Rare IDH1-Mutated AML and Cholangiocarcinoma

Get Seen. Get Noticed. Get Results

ABOUT

COMPANY

Reading List

SUBSCRIBE & FOLLOW

© 2025 Pharmautility, Inc. All rights reserved | Developed by Akshay Prabhale UI Designing Studios